VistaGen Therapeutics Inc Forecast and Stock Analysis
Technical VTGN stock analysis for February 15, 2019.
VistaGen Therapeutics Inc fell by -13.61% in the last day from $1.69 to $1.46 The price has risen in 5 of the last 10 days , but is still down by -12.05% for this period. Volume has increased in the last day by 776 896 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 776 896 shares bought and sold for approximately $1.13 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the VTGN stock was $1.46. This is 13.61% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 16.08% from a day low at $1.43 to a day high of $1.66.
30 day high of the VTGN stock price was $1.86 and low was $1.43.
90 day high was $1.90 and low was $1.26.
52 week high for the VistaGen Therapeutics Inc - $2.44 and low - $0.81.
VistaGen Therapeutics Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.51% during the next 3 months and, with 90% probability hold a price between $1.19 and $1.85 at the end of this period.
There are few to none technical positive signals at the moment. VistaGen Therapeutics Inc holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $1.67 and $1.63. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday February 12, 2019, which indicates further falls until a new bottom pivot has been found. VistaGen Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSI14 is 39 and the stock is currently not being overbought or oversold
Support & Resistance
VistaGen Therapeutics Inc finds support from accumulated volume at $1.45.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.23 (16.08%) between high and low. For the last week, the stock has had a daily average volatility of 8.58%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
VistaGen Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.